Top Durham, NC Pharmaceutical Companies (16)
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. We are powered by technology. Our Global Research Technologies, Medical Devices as a software, and Data Science teams are on the cutting edge of developing and supporting our life-saving medications.
Flatiron Health is a healthtech company dedicated to helping cancer centers thrive and deliver better care for patients today and tomorrow. Through clinical and data science, we translate patient experiences into real-world evidence to improve treatment, inform policy, and advance research. Cancer is smart. Together, we can be smarter. Flatiron Health is an independent affiliate of the Roche Group.
Our purpose ensures that patients remain at the center of all we do. We live our purpose by sourcing the best science in the world; partnering with others in the healthcare system to improve access to our medicines; using digital technologies to enhance our drug discovery and development, as well as patient outcomes; and leading the conversation to advocate for pro-innovation/pro-patient policies.
Who We Are Triangle Insights Group is a strategy consulting firm providing guidance on the most critical business issues to leaders in life sciences organizations. The firm’s approach combines deep knowledge of the industry, across therapeutic areas and functional groups, with a dedication to creativity and strong critical thinking. Recommendations from Triangle Insights Group are original, relevant to the industry environment, and supported by rigorous analytics. Our Vision Our goal is ambitious: to redefine how you think about life sciences consultancies. To replace confusion with clarity. To deliver insights and strategies that foster confidence. Through every step of our customized approaches, you’ll benefit from the personal attention of an entire team of accomplished advisors —their collective vision, collaborative approach and total commitment. Our History Triangle Insights Group, established in April 2013, is an entrepreneurial company. The founding partners are experienced strategy consultants whose backgrounds include Campbell Alliance, Mercer, Boston Consulting Group, and Boston Healthcare. In 2022, the firm was acquired by TrialCard.
Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal.
Tergus Pharma is an end-to-end service provider for topical pharmaceutical products supporting early phase research and formulation, drug development, testing, and both clinical and commercial manufacturing at our new 100,000 sq. ft. state-of-the-art facility in Durham, North Carolina. Tergus is the industry leader for topical/skin semi-solids and liquids as well as other non-skin semi-solids/liquids for vaginal, rectal and otic/ophthalmic routes of administration where we recognize the value of our stellar industry reputation for delivering quality results to clients. With industry-recognized leadership and expertise in method development, such as IVRT/IVPT for topical pharmaceuticals, Tergus also provides clients with peace of mind and helps them to de-risk their product development. Exclusively focused on topical development and manufacturing, Tergus brings the scientific expertise that helps our clients achieve the right balance of scientific knowhow, speed of results, and quality in product service, warranting our company motto, “Think Topicals, Think Tergus.
Partnering to Advance Human Health A unique culture delivering exceptional solutions: Almac is a financially secure, privately owned organisation with 7,500 employees globally. 600+ companies worldwide, including all the market leaders, use our services, testament itself to the quality, innovation and efficiency of our business as proven over the past 50 years. Our vast range of services include: Biomarker Discovery & Development: Pre-clinical biomarker discovery, through to full companion diagnostic development and clinical test delivery from our CLIA lab. API Services & Chemical Development: Services for all stages of drug development for small molecules, potent and cytotoxic compounds and peptides. Pharmaceutical Development: Developing clinical candidates into an optimum formulation and manufacturing drug product for all phases of clinical trial supply. Analytical Services: Delivering comprehensive solutions supporting drug substance and product development programmes. Clinical Trial Supply: Comprehensive global clinical supply chain solutions providing physical resources and supportive technologies ensuring your clinical supply chain continually delivers across the globe. Clinical Technologies: Providing randomisation and trial supply management technology, electronic Clinical Outcome Assessments (eCOA), patient alerts and reminders, data integration and biostatistical consulting services. Commercial Services: Providing commercial manufacturing and packaging solutions and supporting commercial product launch. Find out about our exceptional career opportunities: http://www.almacgroup.com/careers and join our talent network https://www.almacgroup.com/careers/talent-network/
MedPharm is a world-leading contract provider of topical and transdermal product design and development services. Our delivery of robust and innovative research has commanded recognition from regulators and investors alike. We utilise our unique cost-effective performance testing models to mitigate risk and accelerate development times.
Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 21,000 global professionals collaborates with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas, while our innovation ecosystem offers the best solutions to make every phase of the clinical trial process more efficient. With the people, insight and focus on operational excellence, we work With HeartTM every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference. For more information, visit parexel.com. Community Guidelines Because Parexel’s social media channels are open to the general public and employees, we are not responsible for views expressed other than our own. However, we do not tolerate posts that are: • Abusive, harassing or threatening to others. • Defamatory, offensive, obscene, vulgar or depicting violence. • Hateful targeting by race/ethnicity, age, color, creed, religion, gender, sexual preference or orientation, nationality or political beliefs. • Sexually explicit or pornographic. • Fraudulent, deceptive, libelous, misleading or unlawful. • Referencing criminal or illegal activity. • Spamming. We reserve the right to remove any comments that do not adhere to our guidelines as well as report users who violate the rules of our page.
With local operations in 132 countries, Stiefel is a global leader in the field of dermatology. Stiefel is renowned for its 165-year legacy of innovation in the field of skin health, utilizing a combination of expertise, enthusiasm and imagination to deliver the highest quality, most effective prescription and over-the-counter skin care products available. Stiefel, a GSK company social media channels: Twitter: http://twitter.com/stiefelagskco Facebook: http://www.facebook.com/StiefelGSK Stiefel Laboratories, Inc. was acquired by GlaxoSmithKline in July 2009. The acquisition has created a new world-leading specialist dermatology business. As part of the acquisition, Stiefel Laboratories is now called Stiefel, a GSK company.
Accord Healthcare is a large-scale provider of generic pharmaceuticals in the United States. Our U.S. headquarters is in Durham, North Carolina, near the Research Triangle Park (RTP). Situated in a 7,000-acre pine forest, RTP is one of the largest research parks in the world. Close to three major research universities, the area provides an unparalleled scientific, regulatory, quality, and commercial talent pool. Accord is the commercial arm of Intas Pharmaceuticals, a pioneering biopharmaceutical company operating in India since 1976. Selling in over 75 countries, Accord has a vast global presence. The Accord and Intas networks provide full integration in the functional areas vital to delivering quality excellence and service efficiencies: API and finished dosage form manufacturing, R & D, clinical program management, and the economies of scale inherent in worldwide distribution. Accord is routinely cited in IQVIA presentations to industry as one of the fastest growing pharmaceutical companies in the U.S. Quarter-over-quarter, we consistently accomplish double-digit growth across all the metrics: in dollar sales, scripts filled, and number of units sold. We have accomplished this while undergoing multiple plant expansions across all of our manufacturing sites. Our solid record of maintaining high quality standards while implementing strategic commercial expansion has set us apart in the industry. Accord’s product offerings and pipeline demonstrate our commitment to meeting the needs of healthcare professionals and patients alike. We currently have approval for more than 115 ANDAs and are selling over 290 dosing presentations. We have 52 ANDAs pending at the FDA, and over 115 products in active development. Our pipeline spans a full range of dosage forms: orals, topicals, transdermal patches, liquid, lyophilized and complex injectables.
We offer solutions that bridge artificial intelligence (AI) and machine learning (ML), physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, and consumer goods companies, and regulatory agencies worldwide.
Continuous Precision Medicine™ is a leader in the fight against the opioid epidemic.
We see things from the patients' perspective and believe what comes before and after a drug is just as important as the drug itself. We go #BeyondBiology
MAA Laboratories Inc. is a specialty pharmaceutical company located in the Research Triangle Park region of North Carolina. MAA has developed the NanoCont™ drug development platform as a broadly applicable solution for addressing a variety of drug delivery and development challenges. Our company is dedicated to using the NanoCont™ technology to create advanced medicines that improve patients' lives by addressing unmet clinical needs in a variety of therapeutic areas, including oncology, neurological, and cardiovascular diseases.
Cisplatin and other platinum compounds are essential chemotherapeutic components for many pediatric malignancies. Unfortunately, platinum-based therapies can cause ototoxicity in many patients, leaving many survivors of childhood cancer with permanent and irreversible hearing loss. Permanent hearing loss, even minimal, acquired at a young age has a devastating impact on development, education, and socialization and a lifelong negative impact on Quality of Life. There are no currently approved treatments for the prevention of platinum-induced hearing loss. At Fennec Pharmaceuticals, we are dedicated to the development of our investigational agent, PEDMARK™, for the prevention of ototoxicity in children, and we hope that this will enable more children to retain their hearing. In honor of our namesake, the fennec fox, we strive to embody adaptability and resourcefulness in everything we do. Please see www.fennecpharma.com for more information.
